Logo Image
|Articles|April 4, 2016

Building Regulatory Capacity: MRCT Workshop in Singapore

Author(s)DIA

With the globalization of the pharmaceutical industry, multiregional clinical trials (MRCTs) have steadily increased over the past decade. In March 2016, the Centre of Regulatory Excellence (CoRE), Duke-NUS Medical School Singapore – recently designated as an APEC Center of Excellence (CoE) for regulatory training in MRCTs – organized and hosted the second APEC CoE MRCT Workshop in Singapore, following the successful pilot Workshop in Singapore in 2014.

Read more here.

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: FDA Approves Fayuvi
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Read more
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Addressing MFN Innovation Concerns
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.
Read more